Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis. [electronic resource]
Producer: 20130102Description: 2020-6 p. digitalISSN:- 1462-0332
- Adalimumab
- Adult
- Analysis of Variance
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- drug therapy
- Etanercept
- Female
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Male
- Middle Aged
- Propensity Score
- Prospective Studies
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.